The Folic Acid Problem

Since 1998, the United States government has required that folic acid be added to enriched grain products — breads, cereals, pasta, and flour. The intention was sound: to reduce neural tube defects in newborns. The result was a dramatic nationwide drop in those birth defects. By that measure, the policy worked.

But an accumulating body of research now raises serious questions about what that blanket supplementation is doing to a large portion of the population — particularly those who carry a common genetic variant that prevents the body from processing synthetic folic acid properly.

Folic Acid vs. Folate: A Critical Distinction

Folate is the naturally occurring form of Vitamin B9, found in leafy greens, lentils, liver, avocado, and legumes. The body recognizes and absorbs natural folate directly.

Folic acid is a fully oxidized, synthetic compound that does not occur in nature. Before the body can use it, folic acid must be converted through a multi-step enzymatic process into its active form: 5-methyltetrahydrofolate, commonly called 5-MTHF or methylfolate.

This conversion process depends almost entirely on a single enzyme — methylenetetrahydrofolate reductase — produced by the MTHFR gene.

The MTHFR Gene

The MTHFR gene provides the instructions for producing the enzyme that converts folic acid into a usable form. Two common variants of this gene — known as C677T and A1298C — reduce the efficiency of that enzyme significantly.

Research published in Human Mutation (Wilcken et al., 2003) found that the C677T variant occurs in approximately 10–15% of the general population in its homozygous form (two copies), and in 40–50% in its heterozygous form (one copy). Prevalence varies by ethnicity and is particularly high in those of Mediterranean, Hispanic, and Middle Eastern ancestry.¹

The functional impact is significant:

• Individuals with one copy of C677T show approximately 35% reduced enzyme activity
• Those with two copies show 70% reduced enzyme activity²
• Combinations with the A1298C variant can further compound this reduction

The Problem with Unmetabolized Folic Acid

Researchers have documented the presence of unmetabolized folic acid (UMFA) in human blood since the widespread fortification of the food supply began. A landmark study by Bailey and Ayling (2009) in the Proceedings of the National Academy of Sciences found that UMFA is now detectable in the blood of a majority of Americans — something rarely seen before fortification.³

More recent research has deepened those concerns. A 2025 review in Cureus (Hecker, Layton, and Parker) examined the specific impact on MTHFR C677T carriers, finding that circulating UMFA is associated with cognitive impairment, autism spectrum disorder, cleft lip, and psychiatric conditions including schizophrenia and major depression — suggesting the harm comes not only from folate deficiency, but from the active buildup of the unprocessed synthetic form itself.¹⁰

A separate 2025 study in Nutrients (Gunnala, Buhlman, and Jadavji) found that high dietary folic acid intake promotes measurable changes in inflammation, angiogenesis, and neurotoxicity. Higher supplementation levels were correlated with poorer cognitive function in some individuals, and certain folic acid derivatives produced seizure-like effects at relatively low concentrations in laboratory settings.¹¹

The concern is not simply that the folic acid goes unused. Research suggests it may actively interfere with the body’s ability to use the real folate it receives from food.

A 2006 study published in the American Journal of Clinical Nutrition by Troen et al. found that postmenopausal women with high levels of unmetabolized folic acid showed significantly reduced natural killer (NK) cell activity — a key component of immune defense against viruses and cancer cells.⁴

Dr. Ben Lynch, naturopathic physician and author of Dirty Genes (HarperCollins, 2018), has been among the most prominent voices explaining the downstream effects of UMFA in those with MTHFR variants. His research and clinical work document how blocked folate receptors and disrupted methylation cycles contribute to a wide range of chronic conditions.⁵

The Methylation Cycle and Why It Matters

Methylation is a fundamental biochemical process that occurs billions of times per second in the human body. It governs:

• DNA repair and gene expression
• Production of neurotransmitters including serotonin, dopamine, and norepinephrine
• Detoxification of hormones, heavy metals, and environmental toxins
• Immune system regulation
• Cardiovascular health through the regulation of homocysteine

When MTHFR function is impaired and folic acid cannot be converted, the methylation cycle slows or stalls. One of the most measurable consequences is elevated homocysteine — an amino acid that, when it accumulates, damages blood vessel walls and is associated with increased risk of cardiovascular disease, stroke, and cognitive decline.

A study in the Journal of the American Medical Association (Clarke et al., 1991) was among the first to establish the link between elevated homocysteine and cardiovascular risk.⁶ Subsequent research has confirmed that impaired MTHFR function is one of the leading genetic drivers of elevated homocysteine.⁷

Folic Acid and Cancer Risk

Perhaps the most studied — and debated — concern around high folic acid intake is its potential relationship to cancer.

While adequate folate from food appears to be protective against certain cancers, high-dose synthetic folic acid supplementation has produced more troubling findings in some research:

• A randomized controlled trial published in the Journal of the National Cancer Institute (Figueiredo et al., 2009) found that participants taking 1mg of folic acid daily had a higher risk of colorectal adenoma recurrence compared to placebo.⁸
• A study in Cancer Epidemiology, Biomarkers & Prevention (Mason et al., 2007) noted that the timing of the increase in colorectal cancer rates in the US and Canada corresponded closely with the introduction of mandatory folic acid fortification, though the researchers acknowledged the difficulty of establishing direct causation.⁹

A 2021 review in Genes (Petrone, Bernardo, dos Santos, and Abdelhay) examined MTHFR C677T and A1298C polymorphisms across breast cancer, gliomas, and gastric cancer. The authors found that the C677T variant showed a “strong tendency toward the risk” of breast cancer in both homozygous and heterozygous carriers, and a significant association with gastric cancer — particularly in Asian populations. Ethnicity, dietary folate levels, and vitamin B6 and B12 status were all identified as critical variables in interpreting cancer risk across different groups.¹²

The prevailing hypothesis is that folic acid may promote the growth of pre-existing precancerous cells rather than cause cancer from scratch — underscoring the importance of knowing one’s own genetic and health status before supplementing aggressively.

Symptoms That May Suggest an MTHFR Issue

MTHFR variants are silent at the genetic level, but their downstream effects can be wide-ranging. Clinicians who specialize in functional medicine — including Dr. Lynch — have associated impaired methylation with the following:

• Anxiety, depression, or mood instability resistant to standard treatment
• Chronic fatigue not explained by other causes
• Recurrent miscarriage or difficulty with fertility
• Elevated homocysteine on a blood panel
• Migraines, particularly with aura
• History of blood clots
• Brain fog and poor concentration
• Heightened sensitivity to medications, alcohol, or supplements
• Family history of cardiovascular disease, stroke, or Alzheimer’s

MTHFR variants can be identified through standard genetic testing. Many people have already received this data through consumer services such as 23andMe or AncestryDNA; results can be further analyzed using tools such as Genetic Genie or Dr. Lynch’s Strategene platform.

What to Take Instead

The recommended alternative for those with MTHFR variants — and increasingly recognized as superior for all individuals — is 5-MTHF (methylfolate), the biologically active form of folate. Unlike folic acid, methylfolate requires no enzymatic conversion and is immediately usable by the body.

Dr. Lynch recommends starting at a low dose and increasing gradually, as some individuals — particularly those with additional gene variants — can experience a paradoxical reaction to high-dose methylfolate.

Natural food sources of folate also bypass the conversion problem entirely:

• Dark leafy greens — spinach, romaine, arugula, kale
• Lentils and black beans
• Avocado
• Asparagus and broccoli
• Liver (one of the most concentrated food sources)

What to Avoid

For those with MTHFR concerns, reading supplement and food labels carefully is essential. Folic acid appears in:

• Most standard prenatal vitamins
• Fortified cereals, breads, pasta, and flour
• Many general multivitamins and B-complex formulas
• Some energy drinks and functional beverages

Look for supplements that list folate, 5-MTHF, methylfolate, L-methylfolate, or Metafolin rather than folic acid.

The COMT Connection — Coming in the Next Article

MTHFR does not operate in isolation. Closely linked to it is another gene called COMT (catechol-O-methyltransferase), which governs the breakdown of dopamine, estrogen, and stress hormones. When both MTHFR and COMT variants are present, the combined impact on mood, anxiety, hormonal health, and stress response becomes significantly more complex.

Dr. Lynch addresses both genes in depth in Dirty Genes, noting that understanding COMT is essential for interpreting why some people respond poorly to methylfolate supplementation even when they have confirmed MTHFR variants. That topic will be covered fully in the next article in this series.

---

As with all health information, the research in this area continues to evolve. The findings above represent current peer-reviewed evidence and the clinical perspective of leading practitioners in the functional medicine field. Anyone who suspects MTHFR-related issues is encouraged to work with a qualified healthcare provider — ideally one familiar with methylation and nutrigenomics — before making changes to supplementation.

Disclaimer: This article is for informational and educational purposes only and does not constitute medical advice. Always consult a qualified healthcare provider before making changes to your supplement routine or health plan.